Loading...

China Oncology

30 October 2022, Volume 32 Issue 10
Specialists'Article

Current status and research hotspots of cardio-oncology based on bibliometrics

LI Mengjuan, LIU Ying, ZHANG Yanli, LIU Mengyao, XUE Yanan, SU Liping, ZHANG Xiujie, SHI Tieying, FANG Fengqi, LIU Jiwei, XIA Yunlong

2022, 32 (10): 925-935. doi: 10.19401/j.cnki.1007-3639.2022.10.001

Abstract ( 216) PDF (2558KB) ( 894 ) HTML ( 26 )

Different preventive effects of four cardioprotective agents on mice with adriamycin-induced cardiotoxicity

CHEN Yifan, SHEN Yihui, CHENG Leilei, LIN Jinyi, ZHANG Hui, WANG Xuejun, XU Yuchen, ZHANG Jian, GE Junbo

2022, 32 (10): 936-947. doi: 10.19401/j.cnki.1007-3639.2022.10.002

Abstract ( 177) PDF (2320KB) ( 889 ) HTML ( 10 )

Construction of a mouse model of adriamycin-induced cardiomyopathy

ZHANG Qingling, ZHANG Yunpeng, ZHOU Zandong, ZHANG Yue, LIU Tong

2022, 32 (10): 948-959. doi: 10.19401/j.cnki.1007-3639.2022.10.003

Abstract ( 240) PDF (2183KB) ( 997 ) HTML ( 6 )

Specialists' Commentary

Precision therapy in pancreatic cancer: from streamlet towards mainstream

LUO Guopei, YU Xianjun

2022, 32 (10): 960-970. doi: 10.19401/j.cnki.1007-3639.2022.10.004

Abstract ( 291) PDF (1256KB) ( 1338 ) HTML ( 15 )

Article

Value of global longitudinal strain in assessing radiation-induced heart disease in breast cancer: systematic review and meta-analysis

XU Xiaofei, ZHANG Lixia, DAI Heyang, CHEN Lingyun, XUE Jiaojiao, LI Qingxia

2022, 32 (10): 971-978. doi: 10.19401/j.cnki.1007-3639.2022.10.005

Abstract ( 162) PDF (1236KB) ( 843 ) HTML ( 9 )

Expression, localization, biological role and proteomics study of circ-0003910 in HER2-positive breast cancer

ZHU Yi, XIAO Bin, LIU Jiahui, HUANG Ling, SUN Zhaohui, LI Linhai

2022, 32 (10): 979-989. doi: 10.19401/j.cnki.1007-3639.2022.10.006

Abstract ( 193) PDF (4557KB) ( 926 ) HTML ( 6 )

Effect of long non-coding RNA LINC00671 on biological behavior of hepatocellular carcinoma and its mechanism

GUO Tao, SONG Ning, SUN Yuqi, TIAN Jiaqi, TANG Jie, SUN Rongqi, JIANG Yingying

2022, 32 (10): 990-999. doi: 10.19401/j.cnki.1007-3639.2022.10.007

Abstract ( 150) PDF (4107KB) ( 950 ) HTML ( 13 )

Review

New trends and future prospects of regulatory cell death in renal carcinoma

CAO Dalong, YE Dingwei

2022, 32 (10): 1000-1006. doi: 10.19401/j.cnki.1007-3639.2022.10.008

Abstract ( 182) PDF (975KB) ( 511 ) HTML ( 15 )

Research progress of hypoxia-induced mitochondrial autophagy and glucose metabolism reprogramming in gastric precancerous lesions

ZHANG Jiaxiang, ZHOU Yongxue, YAN Shuguang, ZHAO Weihan, DONG Fen

2022, 32 (10): 1007-1015. doi: 10.19401/j.cnki.1007-3639.2022.10.009

Abstract ( 247) PDF (1280KB) ( 620 ) HTML ( 8 )

Guideline and Consensus

Chinese consensus of cardio-oncology in breast cancer

SHEN Zan, SHAO Zhimin, Cancer Support Rehabilitation Therapy Group of Chinese Medical Association Oncology Branch, the Drafting Committee of China Breast Cancer Related Heart Disease Diagnosis and Treatment Consensus

2022, 32 (10): 1016-1036. doi: 10.19401/j.cnki.1007-3639.2022.10.010

Abstract ( 424) PDF (1896KB) ( 1063 ) HTML ( 29 )

中国癌症杂志
    Database Indexing
  • A Guide to the Core Journals of China
  • Chinese Science Citation Database (CSCD)
  • China National Knowledge Infrastructure (CNKI)
  • Chinese Sci-tech Paper and Citation Database (CSTPCD)
  • Outsanding S&T Journals of China (2020) (F5000)
  • World Journal Clout Index (WJCI) Report of Scientific and Technological Periodicals (2021)
  • SCOPUS
  • EMBASE
  • DOAJ
  • Chemical Abstracts (CA)
  • Japan Science and Technology Database (JST)
  • The Western Pacific Region Index Medicus (WPRIM)
  • EBSCO
  • Index of Copernicus International (ICI)

Competent Authorities

 The Ministry of Education of the People’s Republic of China

Sponsored by

 Fudan University Shanghai Cancer Center

Edited by

 Editorial Board of China Oncology

Editor-in-Chief

 SHAO Zhimin

Honorary Editor-in-Chief

 TANG Zhaoyou, CAO Shilong, SHEN Zhenzhou

Printed by

 Shanghai Ouyang Printing Co., Ltd.

WeChat